Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18694522rdf:typepubmed:Citationlld:pubmed
pubmed-article:18694522lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:18694522lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:18694522lifeskim:mentionsumls-concept:C1638187lld:lifeskim
pubmed-article:18694522lifeskim:mentionsumls-concept:C0086661lld:lifeskim
pubmed-article:18694522lifeskim:mentionsumls-concept:C0007102lld:lifeskim
pubmed-article:18694522lifeskim:mentionsumls-concept:C0754515lld:lifeskim
pubmed-article:18694522lifeskim:mentionsumls-concept:C1099354lld:lifeskim
pubmed-article:18694522lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:18694522lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:18694522lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:18694522lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:18694522pubmed:dateCreated2008-8-29lld:pubmed
pubmed-article:18694522pubmed:abstractTextThe c-Myc and human telomerase reverse transcriptase gene (hTERT) gene are frequently deregulated and overexpressed in malignancy. hTERT activity is induced by c-Myc and strategies designed to inhibit c-Myc expression in cancer cells may have considerable therapeutic value. We designed and used a short hairpin RNA to inhibit c-Myc expression in Colo 320 cells and validated its effect on cell proliferation. In this study, four c-Myc-shRNA expression vectors were constructed and introduced into Colo 320 cells. The effects of c-Myc silencing on tumor cell growth was assessed by soft agar assay and DNA synthesis experiments. The expressions of c-Myc and hTERT were also assessed by real-time reverse transcription-polymerase chain reaction and Western blot analysis. Upon transient transfection with plasmid encoding shRNA, it was found that expression of c-Myc and hTERT decreased in shRNA-transfected cells. The downregulation of c-Myc and hTERT inhibited cell growth, shortened telomere lengths, and suppressed telomerase activity. In conclusion, our findings demonstrate that shRNA of c-Myc can inhibit the DNA replication in Colo 320 cells effectively and reduce telomere length and telomerase activity, therefore, it could be used as a new potential anticancer tool for therapy of human colon cancer.lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:languageenglld:pubmed
pubmed-article:18694522pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:citationSubsetIMlld:pubmed
pubmed-article:18694522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18694522pubmed:statusMEDLINElld:pubmed
pubmed-article:18694522pubmed:issn1756-9966lld:pubmed
pubmed-article:18694522pubmed:authorpubmed-author:SeckGGlld:pubmed
pubmed-article:18694522pubmed:authorpubmed-author:NanasiPPlld:pubmed
pubmed-article:18694522pubmed:authorpubmed-author:XiaoHongHlld:pubmed
pubmed-article:18694522pubmed:authorpubmed-author:HuangHaoHlld:pubmed
pubmed-article:18694522pubmed:authorpubmed-author:HuangGuofuGlld:pubmed
pubmed-article:18694522pubmed:authorpubmed-author:XiongWeiWlld:pubmed
pubmed-article:18694522pubmed:authorpubmed-author:FuLeiLlld:pubmed
pubmed-article:18694522pubmed:authorpubmed-author:SuWenWlld:pubmed
pubmed-article:18694522pubmed:authorpubmed-author:HuangHanjuHlld:pubmed
pubmed-article:18694522pubmed:authorpubmed-author:WuYanxiaYlld:pubmed
pubmed-article:18694522pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18694522pubmed:volume27lld:pubmed
pubmed-article:18694522pubmed:ownerNLMlld:pubmed
pubmed-article:18694522pubmed:authorsCompleteYlld:pubmed
pubmed-article:18694522pubmed:pagination27lld:pubmed
pubmed-article:18694522pubmed:dateRevised2010-1-21lld:pubmed
pubmed-article:18694522pubmed:meshHeadingpubmed-meshheading:18694522...lld:pubmed
pubmed-article:18694522pubmed:meshHeadingpubmed-meshheading:18694522...lld:pubmed
pubmed-article:18694522pubmed:meshHeadingpubmed-meshheading:18694522...lld:pubmed
pubmed-article:18694522pubmed:meshHeadingpubmed-meshheading:18694522...lld:pubmed
pubmed-article:18694522pubmed:meshHeadingpubmed-meshheading:18694522...lld:pubmed
pubmed-article:18694522pubmed:meshHeadingpubmed-meshheading:18694522...lld:pubmed
pubmed-article:18694522pubmed:meshHeadingpubmed-meshheading:18694522...lld:pubmed
pubmed-article:18694522pubmed:meshHeadingpubmed-meshheading:18694522...lld:pubmed
pubmed-article:18694522pubmed:meshHeadingpubmed-meshheading:18694522...lld:pubmed
pubmed-article:18694522pubmed:meshHeadingpubmed-meshheading:18694522...lld:pubmed
pubmed-article:18694522pubmed:meshHeadingpubmed-meshheading:18694522...lld:pubmed
pubmed-article:18694522pubmed:year2008lld:pubmed
pubmed-article:18694522pubmed:articleTitlesiRNA directed against c-Myc inhibits proliferation and downregulates human telomerase reverse transcriptase in human colon cancer Colo 320 cells.lld:pubmed
pubmed-article:18694522pubmed:affiliationCenter of Experimental Medicine, Wuhan No,1 Hospital, Wuhan, 430022, PR China. hao4@163.comlld:pubmed
pubmed-article:18694522pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18694522pubmed:publicationTypeRetracted Publicationlld:pubmed
pubmed-article:18694522pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18694522lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18694522lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18694522lld:pubmed